Filter Integrity Limited is a UK based company supporting aerosol scientists and filtration product developers by providing both technical consultancy and specialised aerosol generation and characterisation instruments and equipment.
We are located at the North East Technology Park – NETPark, Sedgefield, County Durham in the North East of England. We are proud to be a UK partner of Palas GmbH, manufacturer of innovative particle and aerosol technology.
Since 2002 Cambustion have offered a range of aerosol instruments designed for aerosol science & laboratory applications.
The Aerodynamic Aerosol Classifier (AAC)adds a unique and novel measurement technique to Cambustion’s range of aerosol instruments.
The Centrifugal Particle Mass Analyser (CPMA) offers researchers the ability to characterise particle density and morphology.
The flexible sampling capabilities and and rapid response times of Cambustion’s established DMS500 and SCS systems make these highly suited to aerosol laboratory work.
We develop, produce and offer instruments and solutions for the measurement and monitoring of aerosol particles. Swisens revolutionizes environmental and process monitoring with new measurement methods and the automatic identification of particles in real time.
Company Profile
At Acoem, we create environments of possibility — helping organisations find the right balance between progress and preservation — safeguarding businesses and assets, and maximising opportunities while conserving the planet’s resources. We deliver unrivalled, interoperable AI-powered sensors and ecosystems that empower our customers to make enlightened decisions based on accurate information.
Together with 150 distributors, our 800+ employees work across 27 offices, 5 manufacturing facilities and 3 R&D centres in 11 countries, to provide trusted, holistic data solutions for customers worldwide.
Acoem links possibilities with protection.
For more information visit acoem.co.uk
The world has changed a lot since TSI started building instruments in 1961, but some things remain the same. TSI’s commitment to our customers’ success, our dedication to research, and our drive to make the world a better place have always been part of our history.
Recently, TSI refined our Mission and Vision Statements, as well as articulated our Guiding Principles. A company’s Mission establishes a foundation for the organization. A Mission is the reason the company exists. Why are we here? What problems do we solve for our customers? A Vision describes what the future looks like if we are successful in delivering our Mission.
TSI Mission: TSI provides trusted measurement, application guidance, and data analytics solutions that enable our customers to make informed decisions.
TSI Vision: Creating a better world by helping protect people, products, and the environment.
To deliver our Mission and achieve our Vision, TSI must live our Guiding Principles. These principles are the basis of how we behave—every day, every interaction, everywhere in the world.
Cormica is GMP, GLP and ISO 17025 accredited offers high-quality testing services for medical devices, pharmaceuticals, and combination products, ensuring they are safe, reliable, and ready for those who depend on them the most.
Cormica offers one of the largest ranges of testing including Analytical Chemistry, Microbiology, Sterility, Physical and Functional Testing…
Medical device company, developing a revolutionary nebuliser for the efficient inhalation delivery of a wide range of medicine formulations. Our deep-tech approach, combines acoustic actuation of drugs with phononic lattices, enabling the nebulisation of a wide range of inhaled medicines. This improves delivery efficiency and controls the localisation within the lungs. Importantly, using new actuations, we have demonstrated that we can nebulise fragile, high value biologics, with the potential to provide effective delivery of biologics (such as micro-RNAs, siRNAs, mRNA, oligonucleotides) that cannot be currently administered effectively with competing approaches. Award-Winning Technology: Acu-Flow received the Convention on Pharmaceutical Ingredients (CPHI) 2024 Start-up Initiative Award.
Our vision is to become a globally renowned company enabling inhalation delivery of innovative formulations which are hard to nebulise, such as biologics (eg RNA treatments). Our technology can deliver these drugs to and through the lungs, not only to treat respiratory disorders, but, in the longer term, to also provide a new route for drug delivery to the central nervous and cardiovascular systems.
